azomycin has been researched along with Parasitemia in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (4.12) | 18.2507 |
2000's | 15 (15.46) | 29.6817 |
2010's | 58 (59.79) | 24.3611 |
2020's | 20 (20.62) | 2.80 |
Authors | Studies |
---|---|
Brancaglion, GA; Caldas, IS; Caldas, S; Carvalho, DT; Diniz, LF; Gonçalves-Santos, E; Mazzeti, AL; Novaes, RD; Oliveira, RRG; Silva, LS; Vilas-Boas, DF | 1 |
Barbosa, JMC; Cascabulho, CM; Daliry, A; de Melo, TG; de Oliveira, G; Pedra Rezende, Y; Pereira, ENGDS; Salem, KS | 1 |
Altcheh, J; Ballering, G; Berenstein, AJ; Falk, N; Freilij, H; González, N; Moroni, S; Moscatelli, G | 1 |
Altcheh, J; Bisio, MMC; García-Bournissen, F; Gulin, JEN; Rocco, D; Solana, ME | 1 |
Marín, C; Martín-Escolano, R; Rosales, MJ | 1 |
Altcheh, J; Ballering, G; Bochoeyer, A; Chatelain, E; Falk, N; Freilij, H; Garcia Bournissen, F; Goldsman, A; González, NL; Grippo, M; Jurado, L; Moroni, S; Moscatelli, G | 1 |
Assmann, CE; Bottari, NB; Castro, MFV; Chitolina Schetinger, MR; da Rocha, MIUM; da Silva, AS; da Veiga, ML; de Souza, LAF; Dutra da Silva, A; Ferreira, DASP; Fracasso, M; Gundel, S; Monteiro, SG; Morsch, VM; Ourique, AF; Reichert, KP | 1 |
Caldas, IS; Chagas-Paula, DA; Diniz, LF; Fernandes, VHC; Gonçalves-Santos, E; Mazzeti, AL; Novaes, RD; Oliveira, CM; Rodrigues, MR; Veloso, MP; Vilas-Boas, DF | 1 |
Díaz, ML; Echeverría, LE; Eduardo Nieto, J; González, CI; Hernandez, JCM; López-Romero, LA; Morillo, CA; Ochoa, SAG; Rivera, JD; Rojas, LZ; Suárez, EU | 1 |
Cascabulho, CM; Castro, SL; Demarque, KC; Duque, TLA; Guimarães, ACR; Manso, PPA; Menna-Barreto, RF; Meuser-Batista, M; Moura, KCG; Oliveira, GM; Pelajo-Machado, M; Pinto, MDC | 1 |
Bermúdez, JM; Cid, AG; Davies, C; Micheloud, JF; Negrette, OS; Parada, LA; Ragone, PG; Simonazzi, A | 1 |
Bahia, MT; Caldas, IS; Diniz, LF; Machado, YA; Marques, MJ; Martins-Filho, OA; Mazzeti, AL; Novaes, RD; Santos, LJS; Vilas Boas, BR | 1 |
Caldas, IS; Diniz, LF; Gonçalves, RV; Gonçalves-Santos, E; González-Lozano, KJ; Mendonça, AAS; Novaes, RD; Souza-Silva, TG | 1 |
Arán, VJ; Batista, DDGJ; Batista, MM; Cumella, J; da Silva, CF; de Oliveira, GM; Escario, JA; Fonseca-Berzal, C; Gómez-Barrio, A; Peres, RB; Silva da Gama Nefertiti, A; Soeiro, MNC | 1 |
Altcheh, J; Eagleson, MA; García-Bournissen, F; Gulin, JEN; López-Muñoz, RA; Solana, ME | 1 |
Branquinho, RT; de Lana, M; Milagre, MM; Reis, LES; Silva, GN; Silva, RR; Silva, TM; Torchelsen, FKVDS | 1 |
Gonzalez Garay, AG; Martinez Garcia, M; Reyes, PP; Vallejo, M | 1 |
Batista, LR; Correia, D; da Silva, DAA; da Silva, MV; de Resende, LAPR; de Sousa, RC; Helmo, FR; Lages-Silva, E; Llaguno, M; Machado, JR; Oliveira, CJF; Rodrigues, DBR; Rodrigues, V | 1 |
Aoki, MP; Eberhardt, N; García, MC; Jimenez-Kairuz, AF; Ponce, NE; Sanmarco, LM | 1 |
Abegg, CP; de Abreu, AP; Fernandes, NS; Gomes, ML; Sarto, MPM; Teston, APM; Toledo, MJO | 1 |
Bern, C; Cabeza, J; Castro, R; Clark, T; Gilman, RH; Lora, MH; Lozano, D; Mejia, C; Pajuelo, MJ; Reimer-McAtee, MJ; Terle, J; Torrico, F; Valencia, E | 1 |
Alonso, V; Leonardi, D; Real, D; Rocha, SC; Salomon, CJ; Santos Souza, HF; Serra, E; Silber, AM | 1 |
Kian, D; Massago, M; Toledo, MJO; Zanusso Junior, G | 1 |
Busch, MP; Caillaudeau, J; Cardoso, CS; de Oliveira, LC; Ferreira, AM; Granjon, E; Gueyffier, L; Lee, TH; Liehl, P; Oliveira, CDL; Pottel, H; Ribeiro, ALP; Sabino, EC; Zrein, M | 1 |
Altcheh, J; Bisio, M; García-Bournissen, F; Gulin, JEN; Rocco, DM; Solana, ME | 1 |
Báez, AL; Bazán, PC; Bustamante, JM; Lo Presti, MS; Nakamura, CV; Paglini-Oliva, P; Rivarola, HW; Rodrigues, JHS; Strauss, M | 1 |
Batlle, A; Demaria, A; Frank, FM; Lombardo, ME; Puente, V | 1 |
Albareda, MC; Alvarez, MG; Bua, J; Castro Eiro, MD; Cooley, G; De Rissio, AM; Fernandez, M; Fichera, LE; Laucella, SA; Lococo, B; Natale, MA; Nuñez, M; Scollo, K; Serjan, A; Shen, H; Tarleton, RL; Viotti, R | 1 |
Bahia, MT; Caldas, IS; Caldas, S; Diniz, LF; Menezes, APJ; Nascimento, ÁFDSD; Novaes, RD | 1 |
Bezerra, FS; Costa, GP; Figueiredo, VP; Horta, AL; Leite, ALJ; Menezes, APJ; Pedrosa, TCF; Ramos, CO; Talvani, A; Vieira, PMA | 1 |
Bierrenbach, AL; Busch, MP; Cardoso, CS; Colosimo, EA; Ferreira, AM; Ferreira, JE; Lee, TH; Oliveira, CDL; Oliveira, LC; Reingold, AL; Ribeiro, ALP; Sabino, EC; Silva, JLP | 1 |
Bastos, TM; Efstathiou, A; Gaboriaud-Kolar, N; Meira, CS; Rocha, VPC; Skaltsounis, AL; Smirlis, D; Soares, MBP; Vougogiannopoulou, K | 1 |
Brandão Peres, R; Britto, C; Cristina Demarque, K; da Cruz Moreira, O; de Melo Oliveira, G; de Nazaré Correia Soeiro, M; Diego de Souza Campos, J; Finamore Araújo, P; França da Silva, C; Lima da Costa, K; Machado Cascabulho, C; Meuser Batista, M; Nefertiti da Gama, A; Rocha Simões-Silva, M | 1 |
Gonçalves, RV; Maldonado, IRSC; Mendonça, AAS; Natali, AJ; Novaes, RD; Souza-Silva, TG; Talvani, A | 1 |
Carneiro, CM; Cunha, ELA; Cunha, LM; de Lana, M; de Oliveira, MT; Fonseca, KDS; Torchelsen, FKVDS; Vieira, PMA | 1 |
Gonçalves, RV; Maldonado, IRSC; Natali, AJ; Novaes, RD; Santos, EC; Santos, EG; Souza-Silva, TG; Talvani, A | 1 |
Baez, A; Bazán, PC; Cremonezzi, D; Esteves, B; Fauro, R; Lo Presti, MS; Paglini-Oliva, PA; Rivarola, HW; Sanchez Negrete, O; Strauss, M | 1 |
Cunha, WR; da Silva Ferreira, D; de Albuquerque, S; do Prado Júnior, JC; e Silva, ML; Esperandim, VR; Kuehn, CC; Toldo, MP | 1 |
Bustamante, JM; Craft, JM; Crowe, BD; Ketchie, SA; Tarleton, RL | 1 |
Bahia, MT; Caldas, IS; de Andrade, IM; Diniz, Lde F; Martins, TA; Mazzeti, AL; Ribeiro, I; Talvani, A; Urbina, JA | 1 |
Bucheton, B; Courtois, P; Cuny, G; Daulouède, S; Dethoua, M; Nzoumbou-Boko, R; Semballa, S; Truc, P; Vincendeau, P | 1 |
Beaulieu, C; Black, WC; Isabel, E; Massé, F; Mellon, C; Methot, N; Nath-Chowdhury, M; Ndao, M; Nicoll-Griffith, DA; Vasquez-Camargo, F | 1 |
Bakunov, SA; Bakunova, SM; Batista, MM; da Silva, CF; da Silva, FH; da Silva, PB; Jones, SK; Patrick, DA; Soeiro, Mde N; Tidwell, RR; Timm, BL | 1 |
Arán, VJ; Escario, JA; Fonseca-Berzal, C; Gómez-Barrio, A; Palmeiro-Roldán, R; Torrado-Durán, S; Torrado-Santiago, S | 1 |
Carneiro, ZA; da Silva, RS; Milanezi, C; Santos, M; Sesti-Costa, R; Silva, GK; Silva, JS; Silva, MC | 1 |
Araújo, MS; Carneiro, CM; Lana, Md; Machado-de-Assis, GF; Martins, HR; Martins-Filho, OA; Oliveira, MT; Oliveira-Silva, JC; Paiva, NC | 1 |
Araújo, SM; Barbosa, Md; Gomes, ML; Gruendling, AP; Kaneshima, EN; Massago, M; Monteiro, WM; Teston, AP; Toledo, MJ | 1 |
Anibal, Fde F; Costa, FC; da Silva, MT; de Lima, GM; Portapilla, GB; Silva-Jardim, I; Thiemann, OH | 1 |
Marín, C; Martín-Escolano, R; Olmo, F; Rosales, MJ; Sánchez-Moreno, M; Urbanová, K | 1 |
Glynne, R; Groessl, T; Khare, S; Liu, X; Molteni, V; Rivera, I; Stinson, M; Supek, F; Tuntland, T; Wen, B; Yeh, V | 1 |
Cifuente, D; Lozano, E; Rivarola, HW; Sosa, MA; Spina, R; Strauss, M; Tonn, C | 1 |
Batista, DG; Britto, C; da Silva, CF; de Araújo, JS; Ferreira, CG; Guedes-da-Silva, FH; Lepesheva, GI; Meuser, MB; Moreira, OC; Simões-Silva, MR; Soeiro, Mde N | 1 |
Ciapponi, A; Comandé, D; Cuesta, CB; Hicks, E; Roberts, KN; Sguassero, Y; Sosa-Estani, S | 1 |
Angheben, A; Aprili, G; Bisoffi, Z; Boix, L; Buonfrate, D; Gandini, G; Gobbi, F; Pupella, S | 1 |
Coelho, PL; de Oliveira Cardoso, MV; de Oliveira Filho, GB; de Simone, CA; Espíndola, JW; Ferreira, LF; Ferreira, RS; Lima Leite, AC; Magalhaes Moreira, DR; Meira, CS; Soares, MB | 1 |
Araújo, JS; Bakunov, SA; Bakunova, SM; Batista, DG; Britto, C; Da Silva, CF; Da Silva, PB; Demarque, KC; Fulco, TO; Guedes-da-Silva, FH; Meuser, MB; Moreira, OC; Oliveira, GM; Patrick, DA; Soeiro, MN; Tidwell, RR | 1 |
Cevey, ÁC; Goren, NB; Mirkin, GA; Penas, FN | 1 |
Caldas, IS; Gonçalves, RV; Novaes, RD; Rodrigues, JP; Santos, EC; Sartini, MV; Souza, RL | 1 |
Aoki, MP; García, MC; Jimenez-Kairuz, AF; Manzo, RH; Ponce, NE; Sanmarco, LM | 1 |
Arrúa, EC; Esteva, MI; Fichera, LE; Rial, MS; Salomon, CJ; Scalise, ML | 1 |
Campos-Estrada, C; Castro, L; Cortes, L; Díaz, MV; Kemmerling, U; Lapier, M; López-Muñoz, R; Maya, JD; Miranda, MR; Morello, A; Pereira, CA; Reigada, C; Seguel, V | 1 |
Castillo, C; Cramer, A; González-Herrera, F; Kemmerling, U; Liempi, A; Machado, FS; Maya, JD; Pimentel, P | 1 |
Carrilero, B; Murcia, L; Roig, M; Segovia, M; Simón, M | 1 |
Bahia, MT; Bloomer, WD; Gonçalves, KR; Mazzeti, AL; Mendes, PF; Papadopoulou, MV; Rosenzweig, HS | 1 |
Arantes, JM; Bahia, MT; Carneiro, CM; de Abreu Vieira, PM; de Lana, M; Francisco, AF; Martins, HR; Pedrosa, ML; Silva, M; Tafuri, WL; Veloso, VM | 1 |
Bahia, MT; Caldas, S; Crepalde, GP; de Assis Cáu, SB; de Lana, M; Dos Santos, FM; Machado-Coelho, GL; Veloso, VM | 1 |
Balbinot, MM; Fernandes, CD; Liarte, DB; Romanha, A; Scholl, D; Steindel, M; Tiecher, FM | 1 |
Alba Soto, CD; Fernández, MC; González Cappa, SM; Poncini, CV; Postan, M; Solana, ME | 1 |
Fernández, MC; González Cappa, SM; Solana, ME | 1 |
Bahia, MT; Caldas, IS; Carneiro, CM; Diniz, LF; Lana, M; Machado-Coelho, GL; Martins, TA; Oliveira, Rde P; Santos, DM; Talvani, A | 1 |
Brutus, L; Chippaux, JP; Clavijo, AN; Postigo, JR; Santalla, JA; Schneider, D | 1 |
Bendhack, LM; da Silva, GK; da Silva, RS; Do Valle Matta, MA; Franco, DW; Guedes, PM; Gutierrez, FR; Oliveira, FS; Rodrigues, GJ; Silva, JS; Zamboni, DS | 1 |
Albuquerque, S; do Prado, JC; Kuehn, CC; Loria, RM; Oliveira, LG; Santos, CD; Toldo, MP | 1 |
Bersani-Amado, CA; Cuman, RK; Gomes, ML; Marques-Araujo, S; Pupulin, AR; Takejima, E; Toledo, MJ | 1 |
Batista, Dda G; Batista, MM; Boykin, DW; Britto, CC; de Oliveira, GM; Rodrigues, AC; Soeiro, Mde N; Stephens, CE | 1 |
Combes, V; Grau, GE; Hempel, C; Hunt, NH; Kurtzhals, JA | 1 |
Aguiar, C; Almeida, EA; Batista, AM; Costa, SC; Guariento, ME; Pavan, TB; Wanderley, JS | 1 |
Bahia, MT; Gravel, AS; Lima, WG; Martins, TA; Santos, FM; Talvani, A; Torres, RM | 1 |
Cruz-Zetina, G; del Rio-Rodriguez, R; López, R; Monteon, V; Ramos-Ligonio, A | 1 |
Britto, C; Guhl, F; Lima-Ferreira, C; Marin-Neto, JA; Melo, MF; Moreira, OC; Morillo, CA; Ramírez, JD; Sosa-Estani, S; Velázquez, E | 1 |
Carlier, Y; Cencig, S; Coltel, N; Truyens, C | 1 |
Bahia, MT; Caldas, IS; de Andrade, IM; Diniz, Lde F; do Nascimento, ÁF; Martins, TA; Ribeiro, I; Talvani, A; Torreele, E; Trunz, BB | 1 |
Lopez, MO; Montanari, JA; Morilla, MJ; Petray, PB; Prieto, MJ; Romero, EL | 1 |
Altclas, J; De Rissio, AM; Dictar, M; García, MM; Luna, C; Riarte, A; Salgueira, C; Sinagra, A; Verón, MT | 1 |
Chiari, E; de Castro, AM; Galvão, LM; Luquetti, AO; Rassi, A | 1 |
Araújo-Jorge, T; Cotta-de-Almeida, V; de Castro, SL; de Souza, AP; Olivieri, BP | 1 |
Braz, LM; Gakiya, E; Ibrahim, KY; Lopes, MH; Nunes Westphalen, EV; Oliveira, OC; Sartori, AM; Shikanai-Yasuda, MA | 1 |
Bahia, MT; Caldas, S; de Lana, M; Diniz, LF; Machado-Coelho, GL; Santos, FM; Veloso, VM | 1 |
Bahia, MT; Caldas, IS; Caldas, S; Carneiro, CM; da Matta Guedes, PM; de Lana, M; Talvani, A | 1 |
Britto, C; Cardoso, MA; Hasslocher-Moreno, A; Morel, CM; Oelemann, W; Pirmez, C; Santoro, A; Vanni, CM; Wincker, P; Xavier, SS | 1 |
Murta, SM; Romanha, AJ | 1 |
Bayo, R; Ceraso, D; De Rissio, A; Dengra, C; Dictar, M; Koziner, B; Luna, C; Riarte, A; Segura, E; Sinagra, A; Verón, MT | 1 |
Alves, RO; Gazzinelli, RT; Murta, SM; Romanha, AJ; Ropert, C | 1 |
Bonté, F; Ferreira, ME; Fournet, A; Lavault, M; Nakayama, H; Rojas de Arias, A; Samudio, M; Schinini, A; Torres de Ortiz, S; Vera de Bilbao, N | 1 |
Bottasso, OA; Piaggio, E; Pitashny, M; Revelli, SS; Roggero, E; Wietzerbin, J | 1 |
Bahia, MT; Carneiro, CM; Chiari, E; Lana, M; Tafuri, WL; Toledo, MJ; Veloso, VM | 1 |
Andrade, SG; Andrade, ZA; Lima, ES | 1 |
3 review(s) available for azomycin and Parasitemia
Article | Year |
---|---|
Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Topics: Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Placebos; Randomized Controlled Trials as Topic; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Topics: Adult; Antibodies, Protozoan; Chagas Disease; Child; Chronic Disease; Cohort Studies; Disease Progression; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Hemagglutination Tests; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Randomized Controlled Trials as Topic; Treatment Failure; Trypanocidal Agents; Trypanosoma cruzi; Xenodiagnosis | 2015 |
Chagas disease and transfusion medicine: a perspective from non-endemic countries.
Topics: Adult; Blood Donors; Blood Safety; Chagas Disease; Donor Selection; Emigration and Immigration; Enzyme-Linked Immunosorbent Assay; Europe; Female; Global Health; Health Services Needs and Demand; Humans; Infant, Newborn; Latin America; Male; Mass Screening; Nifurtimox; Nitroimidazoles; North America; Parasitemia; Pregnancy; Pregnancy Complications, Infectious; Transfusion Reaction; Travel; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
2 trial(s) available for azomycin and Parasitemia
Article | Year |
---|---|
Distinct Treatment Outcomes of Antiparasitic Therapy in
Topics: Adolescent; Chagas Disease; Chemokines; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Parasitemia; T-Lymphocytes; Trypanosoma cruzi | 2018 |
Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
Topics: Antibodies, Protozoan; Chagas Disease; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nitroimidazoles; Parasitemia; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
92 other study(ies) available for azomycin and Parasitemia
Article | Year |
---|---|
4-nitrobenzoylcoumarin potentiates the antiparasitic, anti-inflammatory and cardioprotective effects of benznidazole in a murine model of acute Trypanosoma cruzi infection.
Topics: Animals; Anti-Inflammatory Agents; Antiparasitic Agents; Chagas Disease; Disease Models, Animal; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
Topics: Amiodarone; Animals; Chagas Disease; Disease Models, Animal; Drug Therapy, Combination; Heart; Heart Diseases; Heart Function Tests; Humans; Male; Mice; Nitroimidazoles; Parasitemia; Trypanosoma cruzi | 2022 |
Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults.
Topics: Adult; Antibodies, Protozoan; Chagas Disease; Child; Cohort Studies; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Retrospective Studies; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
Miltefosine and Benznidazole Combination Improve Anti-
Topics: Animals; Chagas Disease; Mice; Nitroimidazoles; Parasitemia; Phosphorylcholine; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery.
Topics: Animals; Chagas Disease; Drug Discovery; Life Cycle Stages; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Parasites; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study.
Topics: Adult; Cardiology; Chagas Cardiomyopathy; Chagas Disease; Child; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
Topics: Animals; Chagas Disease; Female; Mice; Nanocapsules; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy.
Topics: Animals; Antiparasitic Agents; Cardiotonic Agents; Cell Line; Chagas Disease; Cytokines; Female; Immunologic Factors; Inflammation; Lactones; Mice; Myocarditis; Nitroimidazoles; Parasitemia; Rats; Sesquiterpenes; Trypanosoma cruzi; Tumor Necrosis Factor-alpha | 2019 |
Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas.
Topics: Acute Disease; Animals; Chagas Disease; Disease Models, Animal; Disease Progression; DNA, Protozoan; Drug Therapy, Combination; Nitroimidazoles; Parasite Load; Parasitemia; Rats; Rats, Wistar; Triazoles; Trypanocidal Agents | 2020 |
Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Chagas Disease; Disease Models, Animal; Electrocardiography; Male; Mice; Naphthoquinones; Nitroimidazoles; Parasitemia; Time Factors; Trypanocidal Agents | 2020 |
Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection.
Topics: Acute Disease; Animals; Antibodies, Protozoan; Aspartate Aminotransferases; Chagas Disease; Chronic Disease; Disease Models, Animal; Excipients; Female; Heart; Mice; Myocardium; Nitroimidazoles; Parasitemia; Poloxamer; Quadriceps Muscle; Random Allocation; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection.
Topics: Amlodipine; Animals; Chagas Disease; Mice; Nitroimidazoles; Parasitemia; Thiazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
Topics: Acetylglucosaminidase; Animals; Chagas Disease; Cytokines; Disease Models, Animal; Drug Combinations; Female; Glycogen; Hepatitis; Mice; Muscle, Skeletal; Myositis; NADH, NADPH Oxidoreductases; Nitroimidazoles; Parasite Load; Parasitemia; Peroxidase; Thioridazine; Transaminases; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant
Topics: Animals; Cell Line; Chagas Disease; Drug Resistance; Drug Therapy, Combination; Humans; Indazoles; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
Topics: Animals; Chagas Disease; Chlorocebus aethiops; Drug Synergism; In Vitro Techniques; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells; Voriconazole | 2020 |
Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Topics: Animals; Chagas Disease; Chlorocebus aethiops; Female; Heart; Inhibitory Concentration 50; Mice; Nitroimidazoles; Parasitemia; Real-Time Polymerase Chain Reaction; Silybin; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2021 |
IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment.
Topics: Chagas Disease; Humans; Immunoglobulin G; Nitroimidazoles; Parasitemia | 2021 |
Improved efficacy and safety of low doses of benznidazole-loaded multiparticulate delivery systems in experimental Chagas disease therapy.
Topics: Animals; Chagas Disease; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2021 |
Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
Topics: Abdominal Wall; Animals; Brazil; Chagas Disease; Esophagus; Heart; Mice; Nitroimidazoles; Parasite Load; Parasitemia; Stomach; Trypanocidal Agents; Trypanosoma cruzi | 2021 |
HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
Topics: Adult; Antibodies, Protozoan; Bolivia; CD4 Lymphocyte Count; Chagas Disease; Coinfection; Cross-Sectional Studies; Female; HIV Infections; Humans; Latent Infection; Male; Microscopy; Middle Aged; Nitroimidazoles; Parasite Load; Parasitemia; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi; Viral Load | 2021 |
Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach.
Topics: Alcohols; Animals; Chagas Disease; Chemistry, Pharmaceutical; Child; Chlorocebus aethiops; Contraindications; Dosage Forms; Humans; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Polyethylene Glycols; Propylene Glycol; Solubility; Solvents; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells; Water | 2017 |
Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Topics: Animals; Chagas Disease; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Insect Vectors; Male; Mice; Nitroimidazoles; Oils, Volatile; Parasitemia; Plant Oils; Rhodnius; Syzygium; Trypanocidal Agents; Trypanosoma cruzi | 2018 |
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Biomarkers; Brazil; Chagas Disease; DNA, Protozoan; Humans; Immunoassay; Nitroimidazoles; Parasite Load; Parasitemia; Polymerase Chain Reaction; Sensitivity and Specificity; Serologic Tests; Trypanosoma cruzi | 2018 |
Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Topics: Animals; Brain; Chagas Disease; Chlorocebus aethiops; Disease Models, Animal; DNA, Protozoan; Female; Heart; Humans; Infant; Infectious Disease Transmission, Vertical; Inhibitory Concentration 50; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Myocardium; Nifurtimox; Nitroimidazoles; Parasitemia; Random Allocation; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2018 |
In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Topics: Animals; Chagas Disease; Clomipramine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Inhibitory Concentration 50; Male; Mice; Multivariate Analysis; Muscle, Skeletal; Myocardium; Nitroimidazoles; Parasitemia; Principal Component Analysis; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2018 |
Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
Topics: Animals; Ascorbic Acid; Body Weight; Chagas Disease; Chlorocebus aethiops; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Female; Mice, Inbred C3H; Nitroimidazoles; Parasite Load; Parasitemia; Survival Analysis; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2018 |
Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chronic Disease; Collagen Type III; Disease Models, Animal; Disease Progression; DNA, Protozoan; Dogs; Drug Resistance; Fibrosis; Heart; Myocardium; Nitroimidazoles; Parasite Load; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Carvedilol; Catalase; Chagas Disease; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heart; Male; Mice, Inbred C57BL; Myocardium; Nitroimidazoles; Oxidative Stress; Parasitemia; Protein Carbonylation; Reference Values; Reproducibility of Results; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Time Factors; Trypanocidal Agents; Trypanosoma cruzi | 2018 |
Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
Topics: Aftercare; Brazil; Chagas Disease; Chronic Disease; Follow-Up Studies; Humans; National Institutes of Health (U.S.); Nitroimidazoles; Parasitemia; Prospective Studies; Trypanocidal Agents; Trypanosoma cruzi; United States | 2018 |
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
Topics: Animals; Chagas Disease; Disease Models, Animal; Female; Flow Cytometry; Indoles; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2018 |
Impact of levamisole in co-administration with benznidazole on experimental Chagas disease.
Topics: Animals; Chagas Disease; Drug Therapy, Combination; Female; Levamisole; Male; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis.
Topics: Animals; Antioxidants; Cardiotonic Agents; Catalase; Chagas Cardiomyopathy; Chagas Disease; Cytokines; Disease Models, Animal; Heart; Inflammation; Interleukin-10; Male; Myocarditis; Myocardium; Nitric Oxide; Nitroimidazoles; Parasitemia; Physical Conditioning, Animal; Rats; Rats, Wistar; Superoxide Dismutase; Trypanosoma cruzi; Tumor Necrosis Factor-alpha | 2019 |
Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
Topics: Acute Disease; Animals; Chagas Disease; DNA, Protozoan; Dogs; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Heart; Humans; Itraconazole; Male; Myocardium; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Random Allocation; Trypanocidal Agents | 2019 |
Could pre-infection exercise training improve the efficacy of specific antiparasitic chemotherapy for Chagas disease?
Topics: Animals; Antiparasitic Agents; Cardiotonic Agents; Chagas Disease; Cytokines; Disease Models, Animal; Drug Administration Schedule; Heart; Male; Myocarditis; Nitroimidazoles; Parasitemia; Physical Conditioning, Animal; Rats; Rats, Wistar; Running; Trypanosoma cruzi | 2019 |
Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
Topics: Animals; Chagas Disease; Clomipramine; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Female; Intestines; Kidney; Liver; Male; Mice; Muscle, Skeletal; Myocardium; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
In vivo activity of ursolic and oleanolic acids during the acute phase of Trypanosoma cruzi infection.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Chagas Disease; Disease Models, Animal; Infusions, Parenteral; Interferon-gamma; Interleukin-10; Male; Melastomataceae; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oleanolic Acid; Parasitemia; Random Allocation; Triterpenes; Trypanocidal Agents; Ursolic Acid | 2013 |
New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
Topics: Animals; Biomarkers; CD8-Positive T-Lymphocytes; Chagas Disease; DNA; Drug Resistance; Drug Therapy, Combination; Immunophenotyping; Mice; Mice, Inbred C57BL; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.
Topics: Animals; Antiprotozoal Agents; Chagas Disease; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Nitroimidazoles; Parasitemia; Treatment Outcome; Triazoles; Trypanosoma cruzi | 2013 |
Evaluation of trypanocidal drugs used for human African trypanosomosis against Trypanosoma lewisi.
Topics: Animals; Eflornithine; Female; Humans; Immunocompromised Host; Inhibitory Concentration 50; Melarsoprol; Mice; Nifurtimox; Nitroimidazoles; Parasitemia; Pentamidine; Rats; Rats, Wistar; Suramin; Trypanocidal Agents; Trypanosoma lewisi; Trypanosomiasis | 2013 |
Reversible cysteine protease inhibitors show promise for a Chagas disease cure.
Topics: Administration, Oral; Animals; Area Under Curve; Chagas Disease; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Inhibitory Concentration 50; Life Cycle Stages; Male; Mice; Nitroimidazoles; Parasitemia; Protozoan Proteins; Survival Analysis; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.
Topics: Amidines; Animals; Cell Survival; Chagas Disease; Galactosidases; Male; Mice; Nitroimidazoles; No-Observed-Adverse-Effect Level; Parasitemia; Primary Cell Culture; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
Topics: Animals; Calorimetry, Differential Scanning; Cellulose; Chagas Disease; Chemistry, Pharmaceutical; Crystallization; Deoxycholic Acid; Drug Carriers; Female; Mice; Microscopy, Electron, Scanning; Nitroimidazoles; Parasitemia; Powder Diffraction; Trypanocidal Agents; X-Ray Diffraction | 2014 |
Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
Topics: Animals; Chagas Disease; Drug Resistance; Drug Therapy, Combination; Female; Heart; Humans; Inflammation; Mice; Nitric Oxide; Nitroimidazoles; Parasitemia; Ruthenium; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
Topics: Animals; Antibodies, Protozoan; Area Under Curve; Brazil; Chagas Disease; Child; Disease Models, Animal; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Flow Cytometry; Humans; Inflammation; Mice; Myocardium; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Primary Cell Culture; Remission Induction; Statistics, Nonparametric; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
Topics: Animals; Chagas Disease; DNA, Protozoan; Male; Mice; Nitroimidazoles; Parasitemia; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
In vivo and in vitro auranofin activity against Trypanosoma cruzi: Possible new uses for an old drug.
Topics: Animals; Antirheumatic Agents; Auranofin; Cell Line; Chagas Disease; Female; Fibroblasts; Humans; Inhibitory Concentration 50; Lethal Dose 50; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Random Allocation; Specific Pathogen-Free Organisms; Trypanocidal Agents; Trypanosoma cruzi | 2016 |
An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Topics: Animals; Chagas Disease; Cyclophosphamide; Immunocompromised Host; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Molecular Structure; Nitroimidazoles; Parasitemia; Superoxide Dismutase; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
Topics: 14-alpha Demethylase Inhibitors; Administration, Oral; Animals; Chagas Disease; Clinical Trials, Phase II as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart; Humans; Immunosuppression Therapy; Mice; NIH 3T3 Cells; Nitroimidazoles; Parasitemia; Recurrence; Sterol 14-Demethylase; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
Topics: Administration, Oral; Animals; Chagas Disease; Dimethyl Sulfoxide; Disease Models, Animal; Diterpenes; Heart; Mice; Muscle, Skeletal; Myocardium; Nitroimidazoles; Parasitemia; Salvia; Trypanocidal Agents; Trypanosoma cruzi | 2016 |
Different Therapeutic Outcomes of Benznidazole and VNI Treatments in Different Genders in Mouse Experimental Models of Trypanosoma cruzi Infection.
Topics: 14-alpha Demethylase Inhibitors; Animals; Chagas Disease; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Gene Expression; Imidazoles; Immunosuppressive Agents; Male; Mice; Nitroimidazoles; Oxadiazoles; Parasitemia; Sex Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi.
Topics: Animals; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Hydrazones; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Protozoan Proteins; Structure-Activity Relationship; Thiazolidines; Thiosemicarbazones; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Topics: Amides; Amidines; Animals; Chagas Disease; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Female; Mice; Nitroimidazoles; Parasite Load; Parasitemia; Parasitic Sensitivity Tests; Structure-Activity Relationship; Survival Analysis; Terphenyl Compounds; Trypanocidal Agents; Trypanosoma cruzi | 2016 |
Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Topics: Animals; Cells, Cultured; Chagas Cardiomyopathy; Chagas Disease; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Humans; Immunologic Factors; Inflammation; Interleukin-6; Mice; Mice, Inbred BALB C; Myocytes, Cardiac; NF-kappa B; Nitric Oxide Synthase Type II; Nitroimidazoles; Parasite Load; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi; Tumor Necrosis Factor-alpha | 2016 |
Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
Topics: Acute Disease; Animals; Chagas Disease; Curcumin; Cytokines; Female; Liver; Mice; Myocardium; Nitroimidazoles; Parasitemia; Transaminases; Trypanocidal Agents; Trypanosoma cruzi | 2016 |
Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
Topics: Animals; Chagas Disease; Clomipramine; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Synergism; Heart; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Parasitic Sensitivity Tests; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2016 |
Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
Topics: Animals; Chagas Disease; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Carriers; Female; Life Cycle Stages; Mice; Mice, Inbred C3H; Myocytes, Cardiac; Nanoparticles; Nitroimidazoles; Parasitemia; Particle Size; Poloxamer; Primary Cell Culture; Survival Analysis; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2016 |
Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Topics: Animals; Chagas Disease; Chlorocebus aethiops; DNA, Protozoan; Dose-Response Relationship, Drug; Glutathione; Macrophages; Male; Mice; Mice, Inbred BALB C; Myocardium; Nitroimidazoles; Parasitemia; Pentamidine; Putrescine; Random Allocation; Spermidine; Thymidine; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2016 |
Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.
Topics: Animals; Anticholesteremic Agents; Arachidonate 5-Lipoxygenase; Chagas Cardiomyopathy; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; E-Selectin; Endothelium; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Lipoxins; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardium; Nitroimidazoles; Parasitemia; Simvastatin; Survival Analysis; Trypanocidal Agents; Trypanosoma cruzi; Vascular Cell Adhesion Molecule-1 | 2017 |
Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR.
Topics: Adult; Antibiotic Prophylaxis; Chagas Disease; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Trypanocidal Agents | 2017 |
Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment
Topics: Animals; Chagas Disease; Dose-Response Relationship, Drug; Female; Mice; Nitroimidazoles; Parasitemia; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2017 |
Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
Topics: Analysis of Variance; Animals; Chagas Disease; Deferoxamine; Disease Models, Animal; Drug Therapy, Combination; Hemoglobins; Iron; Liver; Male; Mice; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Random Allocation; Siderophores; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Topics: Animals; Chagas Disease; Cyclophosphamide; Dogs; Drug Resistance; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up.
Topics: Adult; Animals; Case-Control Studies; Chagas Disease; Chronic Disease; Cohort Studies; DNA, Kinetoplast; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Male; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2009 |
Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
Topics: Animals; Antibodies, Protozoan; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD4-Positive T-Lymphocytes; Chagas Disease; Female; Gene Expression Regulation; Hyaluronan Receptors; Immunoglobulin G; Interferon-gamma; Lectins, C-Type; Mice; Nitroimidazoles; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Spleen; Time Factors; Trypanosoma cruzi | 2009 |
Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Topics: Animals; Antibodies, Protozoan; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Chagas Disease; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Hyaluronan Receptors; Immunoglobulin G; Immunophenotyping; Lectins, C-Type; Male; Mice; Mice, Inbred C3H; Muscle, Skeletal; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Spleen; T-Lymphocytes; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
Topics: Animals; Chagas Disease; Cyclophosphamide; Female; Genetic Variation; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Nitroimidazoles; Parasitemia; Secondary Prevention; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Drug Resistance; Drug Synergism; Female; Humans; Macrophages; Mice; Nitric Oxide; Nitric Oxide Donors; Nitroimidazoles; Organometallic Compounds; Parasitemia; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
Topics: Acute Disease; Animals; Chagas Disease; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Interferon-gamma; Interleukin-2; Macrophages, Peritoneal; Male; Nitrites; Nitroimidazoles; Parasitemia; Rats; Rats, Wistar; Species Specificity; Survival Rate; Time Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
Topics: Animals; Chagas Disease; Crotalid Venoms; Drug Therapy, Combination; Formularies, Homeopathic as Topic; Heart; Host-Pathogen Interactions; Intestines; Liver; Male; Mice; Nitroimidazoles; Parasitemia; Plant Extracts; Spleen; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
Topics: Amidines; Animals; Antifungal Agents; Benzamidines; Chagas Disease; Drug Combinations; Furans; Male; Mice; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2011 |
CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin.
Topics: Animals; Brain; Disease Models, Animal; Erythropoietin; Female; Fluorescent Dyes; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Malaria, Cerebral; Mice; Nitroimidazoles; Parasitemia; Plasmodium berghei; Poly(ADP-ribose) Polymerases; Survival Analysis; Treatment Outcome | 2011 |
Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.
Topics: Adult; Age Factors; Antibodies, Protozoan; Chagas Disease; Chronic Disease; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Male; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Retrospective Studies; Treatment Failure; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2012 |
Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease.
Topics: Animal Experimentation; Animals; Antiprotozoal Agents; Chagas Cardiomyopathy; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Heart; Nitroimidazoles; Parasitemia; Prognosis; Trypanosoma cruzi | 2012 |
Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
Topics: Animals; Cardiomyopathies; Chagas Disease; Genotype; Heart; Inflammation; Mexico; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
Topics: Antiprotozoal Agents; Argentina; Brazil; Chagas Cardiomyopathy; Colombia; DNA, Protozoan; Double-Blind Method; Drug Monitoring; Humans; Molecular Diagnostic Techniques; Nitroimidazoles; Parasite Load; Parasitemia; Parasitology; Placebos; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Trypanosoma cruzi | 2013 |
Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
Topics: Amphotericin B; Animals; Chagas Disease; Disease Models, Animal; DNA, Protozoan; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Nifurtimox; Nitroimidazoles; Parasite Load; Parasitemia; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Fexinidazole: a potential new drug candidate for Chagas disease.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Chagas Disease; Disease Models, Animal; Female; Mice; Nitroimidazoles; Parasitemia; Survival Analysis; Treatment Outcome; Trypanosoma cruzi | 2012 |
Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.
Topics: Animals; Chagas Disease; Female; Injections, Intravenous; Liposomes; Liver; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Particle Size; Phospholipids; Rats; Rats, Wistar; Tissue Distribution; Trypanocidal Agents; Trypanosoma cruzi | 2004 |
Chagas disease in bone marrow transplantation: an approach to preemptive therapy.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Chagas Disease; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Middle Aged; Nitroimidazoles; Parasitemia; Retrospective Studies; Trypanocidal Agents | 2005 |
Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cell Culture Techniques; Female; Humans; Male; Middle Aged; Nitroimidazoles; Parasitemia; Trypanosoma cruzi; Trypanosomiasis | 2006 |
Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
Topics: Acute Disease; Animals; B-Lymphocytes; Chagas Disease; Immunity, Cellular; Lymph Nodes; Lymphoid Tissue; Male; Mice; Nitroimidazoles; Parasitemia; Spleen; T-Lymphocytes; Thymus Gland; Trypanocidal Agents; Trypanosoma cruzi | 2006 |
Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brazil; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Female; HIV Infections; Humans; Male; Meningoencephalitis; Middle Aged; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Xenodiagnosis | 2007 |
Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Topics: Animals; Chagas Disease; Cyclophosphamide; Dogs; Drug Resistance; Female; Humans; Immunosuppressive Agents; Mice; Nitroimidazoles; Parasitemia; Serial Passage; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
Topics: Acute Disease; Animals; Chagas Disease; Chronic Disease; Drug Resistance; Heart; Humans; Mice; Myocardium; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation.
Topics: Animals; Antibodies, Protozoan; Base Sequence; Chagas Disease; DNA, Kinetoplast; Humans; Molecular Sequence Data; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Sensitivity and Specificity; Trypanosoma cruzi | 1995 |
In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Topics: Animals; Chagas Disease; Drug Resistance; Male; Mice; Nitroimidazoles; Parasitemia; Parasitology; Phenotype; Trypanocidal Agents; Trypanosoma cruzi | 1998 |
Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia.
Topics: Adult; Bone Marrow Transplantation; Chagas Disease; Chronic Disease; Female; Humans; Immunosuppression Therapy; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitroimidazoles; Parasitemia; Recurrence; Transplantation, Autologous; Transplantation, Homologous; Trypanocidal Agents | 1998 |
In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypansoma cruzi population.
Topics: Animals; Chagas Disease; Cytokines; Drug Resistance; Interleukin-12; Macrophages; Male; Mice; Nitric Oxide; Nitroimidazoles; Parasitemia; Phagocytosis; Trypanocidal Agents; Tumor Necrosis Factor-alpha | 1999 |
Efficacy of the bisbenzylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model.
Topics: Acute Disease; Administration, Oral; Alkaloids; Animals; Benzylisoquinolines; Chagas Disease; Chronic Disease; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunoblotting; Isoquinolines; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Trypanocidal Agents | 2000 |
Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Cells, Cultured; Chagas Disease; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Heart; Interferon-gamma; Macrophages, Peritoneal; Male; Myocarditis; Myocardium; Nitric Oxide; Nitroimidazoles; Parasitemia; Rats; Rats, Inbred Strains; Recombinant Proteins; Trypanocidal Agents; Trypanosoma cruzi | 2001 |
Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
Topics: Animals; Chagas Disease; Dogs; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Mice; Nitroimidazoles; Parasitemia; Parasitology; Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2001 |
TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi.
Topics: Acute Disease; Animals; Chagas Disease; Disease Susceptibility; Immunoenzyme Techniques; Macrophages; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Necrosis; Nitroimidazoles; Parasitemia; Spleen; Survival Rate; Trypanocidal Agents; Tumor Necrosis Factor-alpha | 2001 |